You are here

NEA

Pfizer, NEA back Cydan II’s plans to launch a fresh slate of biotech startups focused on rare genetic diseases

Endpoints

Wed, 10/18/17 - 08:45 am

Top biotech investor NEA outlines plans for another $2.5B-plus venture fund

Fierce Biotech

Thu, 01/15/15 - 09:11 am

venture capital

Novartis, NEA join $188M gamble on China biotech fund

Fierce Biotech

Wed, 04/9/14 - 11:51 am

NEA leads $16M round for drug-eluting balloon firm

Tue, 10/4/11 - 08:05 pm